| en |
Prospects for financial sustainability of scaling up antiretroviral therapy programs
Kyomuhangi, Lennie
Abstract
The program costs of antiretroviral therapy (ART) were analyzed using the Cape Town Antiretroviral Costing Model (Boulle, et al, (2004). The total ART costs by end of 2008 for starting 18,500 patients in Senegal, 82,000 patients in Uganda and 165,000 in Kenya were estimated at US$ 20.5 million, US$ 68 million and US$ and US$ 126 million respectively. The lifetime costs per patient on treatment were estimated at US$ 5,015 for Uganda, US$ 5,782 for Senegal, and US$ 6,186 for Kenya. The available funds for ART are about US$ 79 million for Senegal, US$ 74 million for Uganda and US$ 94 million for Kenya. Senegal has committed about US$ 13.3 million from its domestic budget and acquired a loan of US$ 40 million from the World Bank for ART services. Kenya has so far allocated only US$ 1.4 million from the national budget for its ART services. There are no funds from the government budget directed for the ART program in Uganda. The three countries are mainly depending on donor funding. The study concluded that ART services in Uganda and Kenya might not be financially sustainable whereas Senegal may be able to financially its ART program if the current low prevalence levels and political and financial commitment prevail.
|
